Literature DB >> 24704028

Cepharanthine inhibited HIV-1 cell-cell transmission and cell-free infection via modification of cell membrane fluidity.

Kouki Matsuda1, Shinichiro Hattori1, Yuji Komizu2, Ryusho Kariya1, Ryuichi Ueoka2, Seiji Okada3.   

Abstract

The anti-HIV-1 activity of cepharanthine (CEP), a natural product derived from Stephania cepharantha Hayata, was evaluated. CEP stabilized plasma membrane fluidity and inhibited HIV-1 envelope-dependent cell-to-cell fusion of HIV-1-infected cells as well as cell-free infection. It is suggested that CEP inhibited the HIV-1 entry process by reducing plasma membrane fluidity, and the plasma membrane is therefore an identical target to prevent viral infection.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell fusion; Cepharanthine; HIV-1; Membrane fluidity; Viral infection

Mesh:

Substances:

Year:  2014        PMID: 24704028     DOI: 10.1016/j.bmcl.2014.03.041

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  13 in total

1.  Microwave-Assisted Extraction Followed by Solid-Phase Extraction for the Chromatographic Analysis of Alkaloids in Stephania cepharantha.

Authors:  Ying Liu; Daotao Xie; Yun Kang; Yaqin Wang; Ping Yang; Jixian Guo; Jianming Huang
Journal:  J Chromatogr Sci       Date:  2016-01-11       Impact factor: 1.618

Review 2.  Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.

Authors:  Hua Luo; Chi Teng Vong; Hanbin Chen; Yan Gao; Peng Lyu; Ling Qiu; Mingming Zhao; Qiao Liu; Zehua Cheng; Jian Zou; Peifen Yao; Caifang Gao; Jinchao Wei; Carolina Oi Lam Ung; Shengpeng Wang; Zhangfeng Zhong; Yitao Wang
Journal:  Chin Med       Date:  2019-11-06       Impact factor: 5.455

Review 3.  Potential COVID-19 therapeutics from a rare disease: weaponizing lipid dysregulation to combat viral infectivity.

Authors:  Stephen L Sturley; Tamayanthi Rajakumar; Natalie Hammond; Katsumi Higaki; Zsuzsa Márka; Szabolcs Márka; Andrew B Munkacsi
Journal:  J Lipid Res       Date:  2020-05-26       Impact factor: 5.922

Review 4.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

Review 5.  Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products.

Authors:  Ramandeep Kaur; Pooja Sharma; Girish K Gupta; Fidele Ntie-Kang; Dinesh Kumar
Journal:  Molecules       Date:  2020-04-29       Impact factor: 4.411

6.  Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments.

Authors:  Nabab Khan; Xuesong Chen; Jonathan D Geiger
Journal:  Front Pharmacol       Date:  2020-10-29       Impact factor: 5.810

7.  Alkaloids: Therapeutic Potential against Human Coronaviruses.

Authors:  Burtram C Fielding; Carlos da Silva Maia Bezerra Filho; Nasser S M Ismail; Damião Pergentino de Sousa
Journal:  Molecules       Date:  2020-11-24       Impact factor: 4.411

8.  Cepharanthine hydrochloride reverses the mdr1 (P-glycoprotein)-mediated esophageal squamous cell carcinoma cell cisplatin resistance through JNK and p53 signals.

Authors:  Pengjun Zhou; Rong Zhang; Ying Wang; Dandan Xu; Li Zhang; Jinhong Qin; Guifeng Su; Yue Feng; Hongce Chen; Siyuan You; Wen Rui; Huizhong Liu; Suhong Chen; Hongyuan Chen; Yifei Wang
Journal:  Oncotarget       Date:  2017-11-27

9.  Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model.

Authors:  Hua-Hao Fan; Li-Qin Wang; Wen-Li Liu; Xiao-Ping An; Zhen-Dong Liu; Xiao-Qi He; Li-Hua Song; Yi-Gang Tong
Journal:  Chin Med J (Engl)       Date:  2020-05-05       Impact factor: 2.628

Review 10.  Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids.

Authors:  Manuel Torres; Sebastià Parets; Javier Fernández-Díaz; Roberto Beteta-Göbel; Raquel Rodríguez-Lorca; Ramón Román; Victoria Lladó; Catalina A Rosselló; Paula Fernández-García; Pablo V Escribá
Journal:  Membranes (Basel)       Date:  2021-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.